FDA Inspection
Bayer Bitterfeld GmbHBayer Bitterfeld GmbH – FDA Inspection, Mar 23, 2018
Record Details
This FDA Inspection record concerns Bayer Bitterfeld GmbH, with an inspection on March 23, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 0c21df25-23ce-46f8-b2b0-1224723cb8ec
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1048506
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Bayer Bitterfeld GmbH
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 19, 2024 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| July 10, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 8, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 13, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Bayer Bitterfeld GmbH
- FDA Inspection 1272339 - 2024-06-19
- FDA Inspection 1124409 - 2019-07-10
- FDA Inspection 967375 - 2016-04-08
- FDA Inspection 887887 - 2013-12-13
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.